Bibliometric development of Naunyn-Schmiedeberg's Archives of Pharmacology
- PMID: 36280660
- PMCID: PMC9592544
- DOI: 10.1007/s00210-022-02307-2
Bibliometric development of Naunyn-Schmiedeberg's Archives of Pharmacology
Erratum in
-
Correction to: Bibliometric development of Naunyn-Schmiedeberg's Archives of Pharmacology.Naunyn Schmiedebergs Arch Pharmacol. 2023 Jan;396(1):171. doi: 10.1007/s00210-022-02335-y. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 36515727 Free PMC article. No abstract available.
Abstract
Motivated by the 150-year anniversary of the Naunyn-Schmiedeberg's Archives of Pharmacology in 2023, we studied the bibliometric development of the journal. We evaluated data from Editorial Reports, Clarivate, and Springer Nature databases. Several parameters representing the journal's performance, such as the impact factor and social impact, were analyzed over the years. We analyzed the journal's meta-data and wrote an algorithm to retrieve cities and countries of origin. We could see a decrease in publications from Germany and an increase in papers from Brazil, China, Egypt, and Iran during the last years. The decrease in publications from Germany is probably a zeitgeist effect because this country places a strong emphasis on high-impact factor papers for academic promotion and winning grants. Germany was the country with the most publications throughout the 100 most-cited articles. Most of these articles were published between 1970 and 1990, when neurotransmitters were the most published topic. Klaus Starke (Freiburg) and Manfred Göthert (Bonn) were prominent drivers of this field. The most common topics nowadays are "Drugs for the Treatment of Malignant Tumor Diseases" and "Immunopharmacology." The internationality of the journal substantially increased after introduction of English as mandatory language in the 1970s. The journal also experienced substantial COVID-19 pandemic-related effects. This paper is not only of relevance for the field of pharmacology but for science in general in the sense that Naunyn-Schmiedeberg's Archives of Pharmacology is a case study for profound changes in a traditional scientific journal, requiring permanent adjustment by editors, referees, publisher, authors, and readers alike. The development of the journal has been strongly influenced by historic and political developments, cultural attitudes (zeitgeist), language changes, global changes in research topics, and eminent individuals who published many papers in Naunyn-Schmiedeberg's Archives of Pharmacology.
Keywords: Bibliometric development; COVID-19 pandemic; Historical development; Meta-data analysis; Research topics ⋅ zeitgeist.
© 2022. The Author(s).
Conflict of interest statement
LBD and FvH have no competing interests. RS is the Editor in Chief of
Figures












Similar articles
-
From Germany to the world: analysis of 25,931 documents (from 1873 to 2025) published in Naunyn-Schmiedeberg's Archives of Pharmacology.Naunyn Schmiedebergs Arch Pharmacol. 2025 May 3. doi: 10.1007/s00210-025-04199-4. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40317317
-
Bibliometric analysis of Naunyn-Schmiedeberg's Archives of Pharmacology (1947-1974).Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep;397(9):7141-7168. doi: 10.1007/s00210-024-03078-8. Epub 2024 Apr 23. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38652278 Free PMC article.
-
Scientific, bibliometric and biographical analysis of 71 Jewish and dissident pharmacologists persecuted in Germany between 1933 and 1945.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun;398(6):6865-6884. doi: 10.1007/s00210-024-03645-z. Epub 2024 Dec 18. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39692900 Free PMC article.
-
The large part German medicine has played in the development of experimental pharmacology in Japan.Naunyn Schmiedebergs Arch Pharmacol. 2023 Jan;396(1):35-42. doi: 10.1007/s00210-022-02308-1. Epub 2022 Oct 25. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 36282300 Review.
-
Oswald Schmiedeberg (1838-1921) : Ninth Pharmacologic‑Historical Forum, 2024, Munich, Germany.Naunyn Schmiedebergs Arch Pharmacol. 2024 Dec;397(12):9591-9596. doi: 10.1007/s00210-024-03306-1. Epub 2024 Jul 23. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 39042158 Free PMC article. Review.
Cited by
-
From Germany to the world: analysis of 25,931 documents (from 1873 to 2025) published in Naunyn-Schmiedeberg's Archives of Pharmacology.Naunyn Schmiedebergs Arch Pharmacol. 2025 May 3. doi: 10.1007/s00210-025-04199-4. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40317317
-
Country-specific citation disparities in Naunyn-Schmiedeberg's Archives of Pharmacology from 2001 to 2024.Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug 14. doi: 10.1007/s00210-025-04499-9. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40810795
-
Germany in pharmacology publishing: 192 articles with 1367 citations in Naunyn-Schmiedeberg's Archives vs. 16,775 articles with 274,225 citations elsewhere.Naunyn Schmiedebergs Arch Pharmacol. 2025 May 1. doi: 10.1007/s00210-025-04224-6. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40310531
-
The Cold War in pharmacology: a bibliometric analysis of Berlin's contributions to Naunyn‑Schmiedeberg's Archives of Pharmacology (1947-1974).Naunyn Schmiedebergs Arch Pharmacol. 2024 Oct;397(10):7963-7980. doi: 10.1007/s00210-024-03115-6. Epub 2024 May 17. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38758226 Free PMC article.
-
Bibliometric analysis of Naunyn-Schmiedeberg's Archives of Pharmacology (1947-1974).Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep;397(9):7141-7168. doi: 10.1007/s00210-024-03078-8. Epub 2024 Apr 23. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38652278 Free PMC article.
References
-
- Hattori Y, Ishii K, Yanai K, Endoh M (2022) The large part German medicine has played in the development of experimental pharmacology in Japan. Naunyn-Schmiedeberg’s Arch Pharmacol (in press) - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical